Market Trends of UAE Cardiovascular Devices Industry
This section covers the major market trends shaping the UAE Cardiovascular Devices Market according to our research experts:
Electrocardiogram Segment is Expected to Witness Significant Growth Rate in the Cardiovascular Devices Market
The electrocardiogram (ECG) segment is expected to hold a significant share of the Cardiovascular Devices Market's growth over the forecast period. ECG monitors are Cardiac Monitoring Devices that record electrical signals from the heart to detect abnormalities. The development of commercially advanced devices, enabled with Bluetooth sensors and mobile app technology, is anticipated to drive the market's growth in UAE. Technological advancements in these devices are driving the segment's growth. Such cardiovascular risk factors among the UAE population contributed to the growing demand for electrocardiograms and other Cardiac Medical Devices to have an early and effective diagnosis of cardiovascular conditions, thereby contributing to the growth of the market studied. According to the World Obesity Atlas report in 2022, the prevalence of obesity among women by 2030 was estimated to be 50%, while in men by 37% in UAE. Obesity is a severe health issue beyond just being an aesthetic concern. Research shows that it is closely related to several illnesses, including type 2 diabetes, sleep disorders, high blood pressure, and cholesterol, all of which are linked to heart disease and stroke.
Additionally, the launch of various advanced cardiovascular diagnostic devices, including Cardiac Rhythm Management Devices, to meet the growing demand for advanced cardiac care is expected to contribute to the growth of the studied segment in the UAE. For instance, in June 2021, Cardiac Insight launched the Cardea SOLO ECG system, a Cardiac Monitoring Device, at Arab Health 2021, the largest healthcare exhibition in the Middle East.
Thus, the factors mentioned above are expected to contribute to the growth of the studied segment over the forecast period.
Remote Cardiac Monitoring is Expected to Witness Notable Growth Rate in the Cardiovascular Devices Market
Remote Cardiac Monitoring is a method by which information from a patient's implantable Cardiac Rhythm Management Device can be communicated directly to a physician's office. Remote Cardiac Monitoring allows remote electrocardiographic monitoring, using advanced Heart Monitoring Equipment, of patients with suspected cardiac arrhythmias or at risk of developing arrhythmias. Factors such as the high prevalence of cardiovascular diseases, the rising geriatric population who are prone to cardiovascular disorders, the need for advanced Cardiovascular Monitoring, and increasing product launches are expected to drive segment growth.
The prevalence of heart disease among the UAE population is expected to drive the demand for remote Cardiac Monitoring Devices, thereby contributing to the growth of the studied segment. For instance, in the article published by Khaleejtimes in November 2022, every year in the UAE around 8,000 and 10,000 patients suffer from a stroke, equating to about 1 patient every hour. Such a high frequency of heart diseases in the UAE is expected to fuel the demand for remote Cardiac Monitoring, thereby boosting segment growth.
Also, the launch of various awareness campaigns for atrial fibrillation among the UAE population is expected to contribute to the growth of the studied segment. For instance, in October 2022, FibriCheck partnered with Pfizer and Altibbi and launched an awareness campaign to detect atrial fibrillation in the United Arab Emirates. Such awareness campaigns are expected to drive the demand for remote monitoring using Cardiac Rhythm Devices to detect the incidence of atrial fibrillation at early stages, thereby contributing to the growth of the market. Likewise, the market strategies adopted by the key players such as collaborations, mergers, and partnerships for the development of remote monitoring solutions are also expected to reflect on the growth of the studied segment. For instance, in March 2022, BioIntellisence partnered with UAE-based Mubadala Health on remote patient monitoring for the usage of Biosticker and BioButton wearable medical devices across the UAE. These devices are useful for continuous tracking of resting heart rate, temperature, respiratory rate, and others. Such innovative remote patient monitoring devices, which function as advanced Heart Monitoring Equipment for continuously monitoring heart rate, are expected to fuel the segment growth.
